{"nct_id":"NCT05023980","title":"A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-09-23","start_date_type":"ACTUAL","primary_completion_date":"2025-07-11","primary_completion_date_type":"ACTUAL","completion_date":"2026-08","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}